Reuters logo
BRIEF-Impax gets FDA approval for generic Renvela tablets
October 23, 2017 / 8:18 PM / a month ago

BRIEF-Impax gets FDA approval for generic Renvela tablets

Oct 23 (Reuters) - Impax Laboratories Inc

* Impax announces FDA approval and launch of generic Renvela (sevelamer carbonate) tablets, 800 mg

* Impax Laboratories Inc - ‍impax has immediately initiated commercialization activities for a generic version of Renvela​

* Impax Laboratories Inc - ‍sales of generic renvela are expected to benefit company’s financial results this year​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below